Kallistatin has been shown to protect against salt-induced renal injury, inflammation, and fibrosis; carbon tetrachloride-induced liver fibrosis; and cardiac remodeling after chronic myocardial infarction via antioxidative stress and inhibition of NF-κB activation20, 21, 33. Here, NFKB1 is linked to Hepatic fibrosis.